Mereniuk, Todd R <br/><br/>
Synthetic lethal targeting of PTEN-deficient cancer cells using selective disruption of polynucleotide kinase/phosphatase.  [electronic resource] 

 -  Molecular cancer therapeutics  Oct 2013 
 - 2135-44 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-12-1093  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--genetics<br/>Cell Line, Tumor<br/>DNA Breaks, Double-Stranded<br/>DNA Repair--genetics<br/>DNA Repair Enzymes--antagonists & inhibitors<br/>Gene Knockout Techniques<br/>HCT116 Cells<br/>Humans<br/>Molecular Targeted Therapy<br/>Neoplasms--drug therapy<br/>PTEN Phosphohydrolase--genetics<br/>Phosphotransferases (Alcohol Group Acceptor)--antagonists & inhibitors<br/>RNA, Small Interfering<br/>Radiation Tolerance--drug effects